Considering the therapeutic importance of DPP4 inhibition for the treatment of T2DM and the chemical diversity among available inhibitors, computational tools have become essential for understanding the relationship between the structure and the activity and guiding the development of new compounds. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.